A recent multicentre randomised controlled trial compared autofluorescence imaging (AFI) with CE for dysplasia detection in colonoscopy surveillance of patients with longstanding UC (FIND-UC). In this study, CE detected significantly more dysplastic lesions per patient compared with AFI. It is unclear whether this increased dysplasia detection also translates to a reduction of dysplasia at follow-up colonoscopy. The aim of this pre-specified study is therefore to prospectively determine whether there is a difference in dysplasia detection at follow-up colonoscopy between UC patients who were randomized to AFI or CE at index colonoscopy for the FIND-UC trial.
Study Type
OBSERVATIONAL
Enrollment
210
Surveillance colonoscopy with chromoendoscopy
Academic Medical Centre
Amsterdam, North Holland, Netherlands
the proportion of patients in which at least one histological proven dysplastic lesions was detected at follow-up colonoscopy.
the proportion of patients in which at least one histological proven dysplastic lesions was detected at follow-up colonoscopy.
Time frame: during surveillance colonoscopy
The proportion of patients in which at least one histological proven neoplastic lesion was detected
The proportion of patients in which at least one histological proven neoplastic lesion was detected
Time frame: during surveillance colonoscopy
The mean number of histological proven neoplastic lesions per patient
The mean number of histological proven neoplastic lesions per patient
Time frame: during surveillance colonoscopy
The proportion of patients in which at least one histological proven sessile serrated lesion was detected
The proportion of patients in which at least one histological proven sessile serrated lesion was detected
Time frame: during surveillance colonoscopy
The mean number of histological proven sessile serrated lesions per patient
The mean number of histological proven sessile serrated lesions per patient
Time frame: during surveillance colonoscopy
Description of dysplasia detected at follow-up colonoscopy (colonic segment, location with respect to a resection scar if visible), or in the resection specimen after proctocolectomy. The proportion of lesions defined as new/missed and recurrent lesion
Description of dysplasia detected at follow-up colonoscopy (colonic segment, location with respect to a resection scar if visible), or in the resection specimen after proctocolectomy. The proportion of lesions defined as new/missed and recurrent lesions detected during surveillance colonoscopy.
Time frame: during surveillance colonoscopy
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.